SOUTH SAN FRANCISCO, Calif. — The Genentech unit of drugmaker Roche Holding AG is pulling the psoriasis treatment Raptiva off the U.S. market be...
AP | ALEXANDER G. HIGGINS | Posted 04.12.2009 | Business
GENEVA — Swiss pharmaceutical giant Roche agreed to pay $46.8 billion to buy the 44 percent of biotech pioneer Genentech that it doesn't already...
Wall Street Journal | RON WINSLOW | Posted 03.21.2009 | Living
New research at Genentech Inc. is challenging conventional thinking about Alzheimer's disease, providing a provocative theory about its cause and sugg...
Lauren Cahn | Posted 10.16.2008 | Living
Maybe a reality check isn't something you want when you're being bombarded with "Breast Cancer Awareness" messages. After all, that would be kind of scary.
New York Times | David Jolly | Posted 07.29.2008 | Business
PARIS -- The Swiss drug maker Roche Holding said Monday that it was offering about $43.7 billion to acquire the 44 percent of the biotechnology compan...
Fortune | Jon Birger and Katie Benner | Posted 03.28.2008 | Business
We'll say this for the U.S. economy: It can take a punch. Consider the blows it has absorbed just this year. The worst real estate crash since the Gr...
AP | Posted 05.09.2009 | Business